“Bimekizumab impact on draining tunnels: A dynamic assessment in patients with moderate to severe HS using pooled Week 48 results from BE HEARD I&II”, J of Skin, vol. 8, no. 6, p. s475, Nov. 2024, doi: 10.25251/skin.8.supp.475.